{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:14:37Z","timestamp":1783581277686,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009406","name":"Centre Hospitalier Universitaire de Nantes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arcped.2026.105513","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:07:22Z","timestamp":1777723642000},"page":"105513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperammonemia in children treated with asparaginase for acute lymphoblastic leukaemia"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2550-4058","authenticated-orcid":false,"given":"L\u00e9a","family":"Bonneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5503-4078","authenticated-orcid":false,"given":"Caroline","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Polard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Odent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5364-7084","authenticated-orcid":false,"given":"Lena","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2026.105513_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000977","article-title":"Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion","volume":"5","author":"Baruchel","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.arcped.2026.105513_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13613-022-01026-4","article-title":"Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database","volume":"12","author":"Balcerac","year":"2022","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.arcped.2026.105513_bib0003","doi-asserted-by":"crossref","first-page":"900\u201123","DOI":"10.1007\/s12010-015-1917-3","article-title":"A comprehensive review on L-asparaginase and its applications","volume":"178","author":"Batool","year":"2016","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.arcped.2026.105513_bib0004","doi-asserted-by":"crossref","first-page":"312\u20115","DOI":"10.1097\/MPH.0000000000001062","article-title":"Symptomatic hyperammonemia with erwinia chrysanthemi-derived asparaginase in pediatric leukemia patients","volume":"40","author":"Gossai","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.arcped.2026.105513_bib0005","first-page":"161\u20114","article-title":"Hyperammonemia secondary to asparaginase: a case series","volume":"22","author":"Nussbaum","year":"2016","journal-title":"J Oncol Pharm Pr Publ Int Soc Oncol Pharm Pr"},{"key":"10.1016\/j.arcped.2026.105513_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30208","article-title":"Symptomatic hyperammonemia secondary to recombinant Erwinia asparaginase","volume":"70","author":"Martin","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.arcped.2026.105513_bib0007","first-page":"103\u20118","article-title":"High incidence of symptomatic hyperammonemia in children with acute lymphoblastic leukemia receiving pegylated asparaginase","volume":"7","author":"Heitink-Poll\u00e9","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.arcped.2026.105513_bib0008","doi-asserted-by":"crossref","first-page":"179\u201186","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the French method and its successive updates","volume":"71","author":"Miremont-Salam\u00e9","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.arcped.2026.105513_bib0009","doi-asserted-by":"crossref","first-page":"757\u201162","DOI":"10.1016\/j.leukres.2015.04.008","article-title":"Glutaminase activity determines cytotoxicity of l-asparaginases on most leukemia cell lines","volume":"39","author":"Parmentier","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.arcped.2026.105513_bib0010","doi-asserted-by":"crossref","first-page":"1710\u20111","DOI":"10.1373\/49.10.1710","article-title":"Measurement of plasma ammonia is affected in patients receiving asparaginase therapy","volume":"49","author":"Laterza","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcped.2026.105513_bib0011","first-page":"365\u201177","article-title":"Molecular basis of hyperammonemia secondary to asparaginase: from therapeutic efficacity to toxicity]","volume":"81","author":"Gallin","year":"2023","journal-title":"Ann Biol Clin (Paris)"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X2600059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X2600059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:25:40Z","timestamp":1783578340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X2600059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0929693X2600059X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2026.105513","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperammonemia in children treated with asparaginase for acute lymphoblastic leukaemia","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2026.105513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie.","name":"copyright","label":"Copyright"}],"article-number":"105513"}}